ZNF267: A Potential Drug Target and Biomarker for Diseases (G10308)
ZNF267: A Potential Drug Target and Biomarker for Diseases
ZNF267 (ZN267_HUMAN), a gene that encodes for a protein known as ZNF267, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ZNF267 is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression and has been shown to be involved in the development and progression of various diseases.
The ZNF267 gene was first identified in 2005 using computational tools such as RNA-Seq and gene expression arrays. The gene encodes for a protein that is composed of 214 amino acids and has been shown to play a role in the regulation of gene expression in various organisms, including humans. ZNF267 has been shown to be involved in the regulation of cell adhesion, cell signaling, and cell cycle progression, among other processes.
One of the most promising aspects of ZNF267 is its potential as a drug target. ZNF267 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, studies have shown that high levels of ZNF267 expression are associated with poor prognosis in patients with colorectal cancer, and that blocking the activity of ZNF267 has been shown to be effective in treating this form of cancer.
In addition to its potential as a drug target, ZNF267 has also been shown to be a potential biomarker for various diseases. For example, studies have shown that ZNF267 levels are elevated in the brains of patients with Alzheimer's disease, and that blocking the activity of ZNF267 has been shown to be effective in treating this form of dementia. Additionally, ZNF267 has been shown to be involved in the regulation of gene expression in various psychiatric disorders, including depression and schizophrenia.
The discovery of ZNF267 has also led to a greater understanding of its role in the regulation of gene expression and the development and progression of various diseases. ZNF267 has been shown to play a role in the regulation of cell adhesion, cell signaling, and cell cycle progression, among other processes. It has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.
In conclusion, ZNF267 is a gene that has the potential to be a drug target and biomarker for various diseases. Its role in the regulation of gene expression and its association with the development and progression of various diseases make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the role of ZNF267 in the regulation of gene expression and its potential as a drug target and biomarker.
Protein Name: Zinc Finger Protein 267
Functions: May be involved in transcriptional regulation
More Common Targets
ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414
